| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10138114 | American Journal of Ophthalmology | 2018 | 29 Pages |
Abstract
Tocilizumab offers a meaningful improvement in activity and severity in corticosteroid-resistant GO. This trial justifies further studies to characterize the role of tocilizumab in GO.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jose V. Perez-Moreiras, Juan J. Gomez-Reino, Jose R. Maneiro, Eva Perez-Pampin, Angel Romo Lopez, Fernando M. RodrÃguez Alvarez, Jesús M. Castillo Laguarta, Aurora del Estad Cabello, MarÃa Gessa Sorroche, Enrique España Gregori, Marco Sales-Sanz,